Skip to content

Probucol for the prevention of atrial fibrillation progression trial (PoP AF trial).

Probucol for the prevention of atrial fibrillation progression trial (PoP AF trial).

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004077
Enrollment
Unknown
Registered
2013-12-20
Start date
2013-07-29
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Probucol +metoprolol:Probucol +metoprolol

Sponsors

Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: a history of paroxysmal atrial fibrillation within preceding 6 months, which should be demonstrated on electrocardiograms (ECG) within 6 months before enrollment, according to the diagnosis standard of 2010 ESC atrial fibrillation prevention guide

Exclusion criteria

Exclusion criteria: (1) persistent AF with a duration >=1 week, and/or permanent AF; (2) serious left main coronary artery disease in coronary angiography; (3) heart failure (NYHA III or IV); (4) history of coronary artery bypass surgery or PCI; (5) history of acute or old myocardial infarction; (6) cardiomyopathy; (7) valvular heart disease; (8) contraindication of Probucol and/or metoprolol; (9) serious liver/renal dysfunction; (10) history of unstable angina pectoris; (11) stroke or transient ischemic attack (TIA) history within preceding three months; (12) must take anti-arrhythmic drugs (including Chinese medicine anti-arrhythmic drugs), except beta blockers; (13) patients have had Probucol and/or metoprolol but cant accept the washout period for 2 weeks; (14) a judgment by the attending physician that patient participation would be inappropriate.

Design outcomes

Primary

MeasureTime frame
atrial fibrillation recurrence;

Contacts

Public ContactTong Liu

Second Hospital of Tianjin Medical University

liutongdoc@126.com+86 13902183163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026